IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Star Imaging and Path Lab IPO is a Book Building listing on BSE SME exchange. The company is based in New Delhi and caters to Healthcare - Hospitals And Clinic sector. Share India Capital Services is the merchant banker of Star Imaging and Path Lab IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 26th March 2025.
Star Imaging and Path Lab IPO posted revenues of ₹ 85.18 crores and PAT of ₹ 12.42 crores in FY25 on annualised basis.
Revenue:
₹ 85.18 Cr.
EBITDA Margin:
27.49 % 
Net Worth: ₹ 37.61 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Financial results of Star Imaging and Path Lab IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Star Imaging and Path Lab IPO PAT Margin is 14.58 % , ROCE (Return on Capital Employed) is 14.11 % as per latest financial. The below table shows Star Imaging and Path Lab IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Star Imaging and Path Lab IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Star Imaging and Path Lab IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Star Imaging and Path Lab IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Star Imaging and Path Lab IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Star Imaging and Path Lab IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Star Imaging and Path Lab IPO reported revenue of ₹ 85.18 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Star Imaging and Path Lab IPO provide insights into sales growth, market demand, and business scalability.
Star Imaging and Path Lab recorded an EBITDA of ₹ 23.42 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Star Imaging and Path Lab Profit After Tax (PAT) is ₹ 12.42 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 85.18 Cr.
EBITDA Margin:
27.49
%
Net Worth: ₹ 37.61 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Star Imaging and Path Lab operates in Healthcare - Hospitals And Clinic and Diagnostic Imaging Services. The Issue is listed on BSE SME in Apr, 2025. Star Imaging and Path Lab IPO size was with Issue price of .
Merchant Banker(s) of Star Imaging and Path Lab IPO: Share India Capital Services Private Limited
Star Imaging and Path Lab IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Star Imaging and Path Lab IPO listed at a listing price of against the offer price of .
The current market price of Star Imaging and Path Lab is .
Why Us?
